Market statusData NSENot investment advice
RUBICON RESEARCH

RUBICON RESEARCH Latest Share Price (RUBICON)

TechnicalsTV Chart
1,778.80
12.10+0.68%
Overall Score58/100
Day range1,767
₹1,778.80
1,835
52-week571
₹1,778.80
1,899
Above low+211.7%
Below high6.3%
Range position91%
Open1,766.70
Prev Close1,766.70
Bid1,778.71100
Ask1,778.89100

TODAY IN ONE LINE

RUBICON edged up 0.7% on light volume, in line with Nifty's -0.0% move.

With a market cap of ₹29,501.8 Cr., it trades at a P/E of 102.12. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume84.2K71%vs 20D avg
Price Band20
Lower Band1,413.4
Upper Band2,120
Tick Size0.10
Daily Volatility2.43%
Annualised Vol46.43%
Market Cap₹29,501.8 Cr.
Promoter23.93%
Face Value₹1
Fwd P/E49.52
PEG
EV/EBITDA33.21
P/S13.22
ROA11.74%
Beta0.45
Div Payout
THE STOCK SCORE
Overall Score58/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

RUBICON RESEARCH flags & news 

Key strengths, potential risks, and recent updates.

5 green flags🚩 5 red flags

Green Flags

  • Earnings GrowthEPS (TTM) grew by a solid 96.6% YoY
  • High Capital EfficiencyROCE of 20.5% indicating pricing power
  • Strong Return on EquityHealthy ROE of 19.1%
  • Healthy Operating MarginsOPM is structurally strong at 20.7%
  • Virtually Debt-FreeVery low Debt-to-Equity of 0.20x

Red Flags

  • Sales ContractionQuarterly sales dropped 19.9% YoY
  • Expensive ValuationTrading at a high P/E ratio of 92.0x
  • Low Promoter HoldingPromoters hold only 23.9%
  • Promoter SellingPromoter holding decreased by 11.96% QoQ
  • Promoter Pledging DetectedPledge activity recorded on 2026-06-30

Latest RUBICON RESEARCH News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

RUBICON RESEARCH valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for RUBICON RESEARCH, framed against the sector median so the premium or discount is obvious at a glance.

RUBICON RESEARCH trades at a P/E of 102.12× and P/B of 22.84×.

Key MetricsMarket + reported · 17 Sept 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹29,501.8 Cr.
P/E Ratio
102.12
P/B Ratio
22.84
EPS
₹4.99
Profitability

Profitability

ROE
19.14%
ROCE
20.49%
Net Margin
13.48%
Op Margin
20.68%
Growth

Growth

EPS YoY
96.6%
Revenue YoY
43.5%
Qtr Sales
-19.95%
Qtr Profit
-2.75%
Financial Health

Financial Health

Debt / Equity
0.2
Book Value
₹77.93
Div Yield
0.08%
Promoter Holding
23.93%
Technicals

RUBICON RESEARCH technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for RUBICON RESEARCH — derived from the latest tape, not yesterday's close.

RUBICON RESEARCH last traded at ₹1,778.8 with an intraday range of ₹1,766.7–₹1,834.9 — latest indicator, pivot and CPR signals below.

Last updated: 17 September 2026, 11:11 am IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹1778.80
LevelPrice (₹)Distance% Δ
R41956.63+177.83+10.00%
R31888.43+109.63+6.16%
R21861.67+82.87+4.66%
R11820.23+41.43+2.33%
PIVOT1793.4714.670.82%
CURRENT1778.80
S11752.03-26.77-1.50%
S21725.27-53.53-3.01%
S31683.83-94.97-5.34%
S41615.63-163.17-9.17%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 1786.13P: 1793.47TC: 1800.80
R1
R2
R3
R4
indicator
LTP: 1778.80
PDH: 1812.30
PDL: 1712.10
● Market Sentiment

RUBICON is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 1766.71811.8

● Price Position

Trading Inside opening range

Financials

RUBICON RESEARCH financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for RUBICON RESEARCH — consolidated or standalone — with margins, YoY growth and key ratios inline.

RUBICON RESEARCH reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹29,501.8 Cr. and reported EPS of ₹4.99.

iTap any row for a plain-English meaningChange vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026
Revenue from Operations
1,754
Other Income
8
Total Income
1,762
556
Gross ProfitDerived
1,198
Gross Margin %Derived
68.30%
798
EBITDA (Operating Profit)Derived
400
OPM %Derived
22.82%
87
Profit Before Tax (PBT)
321
74
Effective Tax %Derived
23.02%
Total Profit for Period
247
Net Profit (Owner's PAT)Derived
247
Net Profit Margin %Derived
14.07%
Earnings Per Share (EPS ₹)
14.95
Diluted Shares Outstanding (Cr)
17
Other Comprehensive Income (Net of Tax)
3
Total Expenses (incl. D&A & Interest)
1,441
Material Cost % of RevenueDerived
35.07%
Employee Cost % of RevenueDerived
14.61%
Other Cost % of RevenueDerived
30.87%
Interest Coverage (x)Derived
8.42x
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

RUBICON RESEARCH segment analysis : revenue and profit mix.

Disclosed business segments at RUBICON RESEARCH with their share of revenue and profit, switchable between consolidated and standalone reporting.

RUBICON RESEARCH discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for RUBICON RESEARCH.

Our AI distills the core fundamental drivers supporting RUBICON RESEARCH, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

RUBICON RESEARCH's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

  • SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 133 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 14% would indicate weaker capital compounding.

Shareholding

RUBICON RESEARCH shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in RUBICON RESEARCH — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

AnnualJun 2026

Promoters23.93%0.04%
DII9.43%0.59%
Public23.30%0.72%
FII7.52%0.02%
Promoter35.83%0.06%

Ownership Distribution

Promoters
23.93%
Domestic Institutions
9.43%
Retail & Public
23.30%
Foreign Institutions
7.52%
Promoter Foreign
35.83%

Category Trends

Foreign Institutions Breakdown
Total Holding: 7.52%
Net Change: -0.02%
Category Total7.52%
Total Holding7.52%
Net Change-0.02%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 2.77%, but category aggregate is 7.52%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
FIDELITY FUNDS - INDIA FOCUS FUND
1.42%
0.00%
0.00%
Jun 2026
NOMURA FUNDS IRELAND PUBLIC LIMITED COMPANY- NOMURA FUNDS IRELAND - INDIA EQUITY FUND
1.35%
0.33%
-0.33%
Jun 2026
AMANSA INVESTMENTS LTD
0.00%
0.00%
0.00%
Jun 2026
Peers

RUBICON RESEARCH peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — RUBICON RESEARCH is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
MANIPAL HEALTH ENTERPRI L
₹94,970.23 Cr
Best Profit Growth
AMBALALSA
13108.64 %
Highest Dividend Yield
JENBURKT PHARMACEUTICAL L
2.13 %

Peer Comparison

Company Name
09 · Chart Patterns

RUBICON RESEARCH chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for RUBICON RESEARCH — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

RUBICON RESEARCH delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for RUBICON RESEARCH over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in RUBICON RESEARCH stood at 49.6% of traded volume, against a 20-day average of 47.4%.

Avg Delivery (20D)47.4%+2.2 ppt latest vs avg
Highest Delivery58.9%on 11 Sept
Avg Volume (20D)2.89 L20-day run-rate
Conviction Trend↑ Strengthening+2.2 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

RUBICON RESEARCH announcements: results, concalls, ratings, M&A.

Filings RUBICON RESEARCH sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

RUBICON RESEARCH files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 73 documents below.

  1. 26 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    Rubicon Research Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 26, 2026. Further, the…

  2. 26 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    Rubicon Research Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 26, 2026

  3. 19 Aug 2026UpdatesView PDF

    Updates

    Rubicon Research Limited has informed the Exchange regarding 'Transcript of Earnings Call Q1 FY 2026-27'.

  4. 15 Aug 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Rubicon Research Limited has informed the Exchange about Copy of Newspaper Publication

  5. 14 Aug 2026General UpdatesView PDF

    General Updates

    Rubicon Research Limited has informed the Exchange about Audio Recording of Earnings Call

Corporate Actions

RUBICON RESEARCH dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue RUBICON RESEARCH has declared, sequenced by announce and record date.

RUBICON RESEARCH corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About RUBICON RESEARCH: business, sector, key facts.

What RUBICON RESEARCH does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

RUBICON RESEARCH operates in the Pharmaceuticals industry under the Healthcare sector.

RUBICON
Healthcare

RUBICON RESEARCH

company facts
Employees
SectorHealthcare
HeadquartersMumbai, India
Market Cap₹29,501.8 Cr.
Listed OnNSE
leadership15 on record
Mr. Louis E. L. Coutinho
Global Quality Head
Mr. Narendra N. Borkar
President & Director of Operations (USA)
Mr. Nitin Jajodia
Chief Financial Officer
Mr. Parag Suganchand Sancheti
CEO & Executive Director
Mr. Sagar Pradeep Oak
Senior Vice President of Corporate Development & Strategy
Mr. Sarabjit Singh
Executive Vice President of Research & Development
Mr. Sudhir Dhirendra Pilgaonkar
Co-Founder, Chief Commercial Officer & Senior VP
Mr. Sumant Sudhir Pilgaonkar
Senior Vice President of Operations
Ms. Avani Harish Shah
General Manager of Secretarial, Legal & Compliance
Ms. Deepashree Omkar Tanksale
Company Secretary & Compliance Officer
Ms. Deepashree Tanksale
Company Secretary & Compliance Officer
Ms. Pratibha S. Pilgaonkar
Co-Founder, MD & Director
§ ∞ · Plainly Answered

Questions investors ask about RUBICON RESEARCH (RUBICON).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of RUBICON RESEARCH (RUBICON)?

The current share price of RUBICON RESEARCH (RUBICON) is ₹1,778.80. Today, the stock has gained by ₹12.10 (0.68%), trading in a range of ₹1,766.70 to ₹1,834.90. The stock opened at ₹1,766.70 with a trading volume of 84,160 shares.

02Is RUBICON RESEARCH stock a good investment for long-term?

RUBICON RESEARCH can be considered for long-term investment based on several factors. The company has a market capitalization of ₹29,501.8 Cr., P/E ratio of 102.12, ROE of 19.14%, and ROCE of 20.49%. The dividend yield stands at 0.08%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of RUBICON RESEARCH stock?

The 52-week high price of RUBICON RESEARCH (RUBICON) is ₹1,899.00, while the 52-week low is ₹570.75. Currently trading at ₹1,778.80, the stock is 211.66% above its 52-week low and 6.33% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy RUBICON RESEARCH stock at the current price?

Whether to buy RUBICON RESEARCH stock at ₹1,778.80 depends on multiple factors. The stock is currently trading with a P/E ratio of 102.12 and P/B ratio of 22.84. Today's performance shows a gain of 0.68%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of RUBICON RESEARCH and when is the next dividend?

RUBICON RESEARCH offers a dividend yield of 0.08%, which means for every ₹100 invested at the current price of ₹1,778.80, you can expect to receive approximately ₹0.08 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of RUBICON RESEARCH?

RUBICON RESEARCH's key financial metrics include: P/E Ratio: 102.12, P/B Ratio: 22.84, ROE: 19.14%, ROCE: 20.49%, Dividend Yield: 0.08%, EPS: ₹4.99, Book Value: ₹77.93, and Debt-to-Equity: 0.2. The company's market cap stands at ₹29,501.8 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is RUBICON RESEARCH stock performing today in the market?

RUBICON RESEARCH stock opened at ₹1,766.70 and is currently trading at ₹1,778.80, showing a gain of ₹12.10 (0.68%). The intraday high is ₹1,834.90 and low is ₹1,766.70. The trading volume stands at 84,160 shares, indicating moderate market participation today.

08What is the P/E ratio of RUBICON RESEARCH and what does it indicate?

RUBICON RESEARCH has a Price-to-Earnings (P/E) ratio of 102.12, which means investors are willing to pay 102.12 for every ₹1 of earnings. With an EPS of ₹4.99, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about RUBICON RESEARCH (RUBICON) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.